EUVIMEDAtrasti EUVIMED
Übersichtsarbeit

Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy

Jiani Lu, Danmei Yu, Hongtao Li, Pengcheng Qin, Hongzhuan Chen, Lili Chen iD

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8185 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, 2025. Written by Jiani Lu and 5 co-authors. Institution: Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Tradi…. Major MEDLINE topics: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Neoplasms, Biological Products, Antineoplastic Agents. Cited 7 times so far (Crossref); 112 references. Funded by: Natural Science Foundation of Shanghai Municipality.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

The development of Src homology‐2 domain containing protein tyrosine phosphatase‐2 (SHP2) inhibitors is a hot spot in the research and development of antitumor drugs, which may induce immunomodulatory effects in the tumor microenvironment and participate in anti‐tumor immune responses. To date, several SHP2 inhibitors have made remarkable progress and entered clinical trials for the treatment of patients with advanced solid tumors. Multiple compounds derived from natural products have been proved to influence tumor cell proliferation, apoptosis, migration and other cellular functions, modulate cell cycle and immune cell activation by regulating the function of SHP2 and its mutants. However, there is a paucity of information about their diversity, biochemistry, and therapeutic potential of targeting SHP2 in tumors. This review will provide the structure, classification, inhibitory activities, experimental models, and antitumor effects of the natural products. Notably, this review summarizes recent advance in the efficacy and pharmacological mechanism of natural products targeting SHP2 in inhibiting the various signaling pathways that regulate different cancers and thus pave the way for further development of anticancer drugs targeting SHP2.

Subjects

MeSH terms (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 11NeoplasmsBiological ProductsAntineoplastic AgentsHumansAnimalsSignal TransductionApoptosisCell Proliferation

Author keywords

SHP2SHP2 inhibitorscancer therapynatural products

Substances

Protein Tyrosine Phosphatase, Non-Receptor Type 11Biological ProductsAntineoplastic AgentsPTPN11 protein, human

Authors and institutions

  • Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Pharmacy, Henan University, Kaifeng, China.

ORCID profiles: Lili Chen

Funding

  • Natural Science Foundation of Shanghai Municipality

Cite

APA

Lu, J., Yu, D., Li, H., Qin, P., Chen, H., & Chen, L. (2025). Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy. Phytotherapy Research. https://doi.org/10.1002/ptr.8185

Vancouver

Lu J, Yu D, Li H, Qin P, Chen H, Chen L. Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy. Phytotherapy Research. 2025. doi:10.1002/ptr.8185

BibTeX
@article{Lu2025,
  author = {Lu, Jiani and Yu, Danmei and Li, Hongtao and Qin, Pengcheng and Chen, Hongzhuan and Chen, Lili},
  title = {Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8185}
}
Start for free →